MedPath

Saddle Block With IT Morphine for Penile Inversion Vaginoplasty

Not Applicable
Not yet recruiting
Conditions
Pain, Postoperative
Registration Number
NCT06556121
Lead Sponsor
Women's College Hospital
Brief Summary

Penile Inversion Vaginoplasty (PIV) is a transition-related surgery (TRS) that is associated with severe postoperative pain. The optimal pain management strategies for this surgery remain unknown. We hypothesized that the addition of a saddle block with intrathecal morphine would yield clinically important analgesic benefits.

Detailed Description

PIV is a TRS offered for male-to-female transition associated with severe postoperative pain despite contemporary analgesic strategies, including opioid-based multimodal systemic analgesia and local anesthetic-based pudendal nerve block. Intrathecal opioids directly target the nociceptors in the spinal cord and can provide potent analgesia for abdominopelvic procedures, including PIV, but are associated with important dose-related adverse effects with rostral spread within the cerebrospinal fluid.

Motor-sparing saddle block using ultra-low dose hyperbaric spinal anesthesia has been successfully implemented as the standard of care for anesthesia in patients undergoing ambulatory perianal procedures at WCH. Saddle block produces reliable sensory anesthesia and long-lasting analgesia of the perineum ("saddle") as the hyperbaric local anesthetic preferentially blocks the small pain fibers of the sacral nerve roots with gravity when the patient is placed in the seated position. With the aim to directly target the opioid nociceptors in the sacral roots and limit rostral opioid spread (and associated opioid-related adverse effects), we recently began to offer a presurgical saddle block with a low dose of intrathecal morphine (100mcg) to patients undergoing PIV at WCH with excellent anecdotal results. Therefore, we are undertaking the present randomized placebo-controlled study to determine whether or not the addition of a saddle block with IT morphine to multimodal systemic analgesia and surgeon-administered pudendal nerve block provides superior analgesia to multimodal systemic analgesia and surgeon-administered pudendal nerve block alone.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Male
Target Recruitment
40
Inclusion Criteria
  • ASA I-III patients
  • Ages 15-70 years
Exclusion Criteria
  • Local infection
  • History of use of over 30mg oxycodone or equivalent per day.
  • Contraindication to a component of multi-modal analgesia
  • Complications or adverse events unrelated to the local anesthetic that precludes evaluation of the primary and secondary outcome measures.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Cumulative opioid (analgesic) consumption48 hours

Consumption intra-operatively, total in-hospital postoperative consumption measured oral morphine equivalents (MEQ)

Secondary Outcome Measures
NameTimeMethod
Pain Assessment (VAS)Up to 48 hours post-operatively

Visual Analogue Scale(VAS) - Pain:Overall pain assessed at rest and on movement A continuous scale comprised of a 100mm (10cm) horizontal line, anchored by 2 verbal descriptions No Pain to Worst Pain

Incidence of opioid-related side effectsUp to 48 hours post-operatively

Itching, respiratory depression, hypotension, nausea and vomiting

Quality of Life scores48 hours post-operatively

Quality of Recovery (QR15) scores at 48 hours will be the second primary outcome.

QR15 is a measurement of quality of recovery after surgery and anesthesia that has been psychometrically tested and validated. Reporting of outcome measures on a scale of 0 to 10 (0=None of the time and 10=All of the time). There are a total of 40 items/questions.

Patient Satisfaction with Analgesic Technique and Pain management24 hours post-operatively

A Patient Diary will be completed to assess overall satisfaction with analgesic technique

Presence of Block-related complicationsUp to 48 hours post-operatively

Persistent paresthesia, post dural puncture headache

Time to first analgesic request24 hours

At recovery room discharge and hospital discharge

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.